Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Welcome to the PROBIP scientific study

 

 

"Identification of criteria for evaluating the effectiveness of treatments for bipolar disorder"

 

 

The aim of this study is to identify the outcomes that matter most to patients, for us to better measure the effectiveness of treatments for bipolar disorder.

 

The study is being conducted by Dr. Astrid Chevance, a researcher at CRESS (Center for Research in Epidemiology and Statistics, Inserm Université Paris Cité).

The study consists of completing an online questionnaire that takes less than 15 minutes to complete.

 

You can participate in this study if you are:

- affected by bipolar disorder (type 1, type 2, or other)

- a caregiver for a loved one affected by bipolar disorder

- a healthcare professional who works with people affected by bipolar disorder

 

 

 

You can save your current questionnaire:

You can save your questionnaire to complete it later.

To do so, please enter a username and password, then click the “Save” button below. To protect your anonymity, we recommend using a pseudonym as your username and not providing an email address.

Your progress will then be saved, and you can resume the questionnaire at any time by logging in again with the same credentials. After clicking “Save,” you can either close your browser or continue answering the questionnaire.

This survey is anonymous.

The record of your survey responses does not contain any identifying information about you, unless a specific survey question explicitly asked for it.

If you used an identifying token to access this survey, please rest assured that this token will not be stored together with your responses. It is managed in a separate database and will only be updated to indicate whether you did (or did not) complete this survey. There is no way of matching identification tokens with survey responses.